Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ruben Fernández-Álvarez"'
Autor:
Ana Batlle-López, Esther González-García, Francisco-Javier Peñalver, Jose Angel Hernandez-Rivas, Ruben Fernández-Álvarez, Mariana Bastos, Miguel A Fuertes, Norma C. Gutiérrez, José-María Moraleda, Carlos Grande, Alejandro Martín, Francisco Gual-Capllonch, José-María Guinea, Eva González-Barca, Olga García, Marc Sorigue, María-Jesús Peñarrubia, Eva Gimeno, Juan-Manuel Sancho
Publikováno v:
Cancer Medicine
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
Cancer Medicine, Vol 10, Iss 4, Pp 1314-1326 (2021)
Dipòsit Digital de la UB
Universidad de Barcelona
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
Cancer Medicine, Vol 10, Iss 4, Pp 1314-1326 (2021)
Dipòsit Digital de la UB
Universidad de Barcelona
The use of non‐pegylated liposomal doxorubicin (Myocet®) in diffuse large B‐cell lymphoma (DLBCL) has been investigated in retrospective and single‐arm prospective studies. This was a prospective phase 2 trial of DLBCL patients ≥60 years old
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcfadc6a5edb3b43a2ca4f8277856414
https://ddd.uab.cat/record/270620
https://ddd.uab.cat/record/270620
Autor:
Eva González-Barca, Ruben Fernández-Álvarez, Helena Pomares, Alejandro Martín, Cristina Motlló, Miriam Moreno, Santiago Mercadal, Esther González-García, Miguel Alcoceba, Anna Sureda, Dolores Caballero, Juan-Manuel Sancho, Sara Alonso, Olga García, Josep-Maria Ribera, Marc Sorigue
Publikováno v:
Hematological Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Follicular lymphoma is characterized by a good response to immunochemotherapy (ICT). However, a small percentage of patients responds poorly to treatment and seems to have a worse outcome. This study attempted to identify the predictive factors and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::842045d7d41b02bd219435685ad6823b
https://doi.org/10.1002/hon.2378
https://doi.org/10.1002/hon.2378
Autor:
Lourdes Hontecillas-Prieto, Daniel J. García-Domínguez, Natalia Palazón-Carrión, Alejandro Martín García-Sancho, Esteban Nogales-Fernández, Carlos Jiménez-Cortegana, María L. Sánchez-León, Silvia Silva-Romeiro, Rocío Flores-Campos, Fernando Carnicero-González, Eduardo Ríos-Herranz, Fátima de la Cruz-Vicente, Guillermo Rodríguez-García, Rubén Fernández-Álvarez, Natividad Martínez-Banaclocha, Josep Gumà-Padrò, José Gómez-Codina, Antonio Salar-Silvestre, Delvys Rodríguez-Abreu, Laura Gálvez-Carvajal, Jorge Labrador, María Guirado-Risueño, Mariano Provencio-Pulla, Margarita Sánchez-Beato, Lejeune Marylene, Tomás Álvaro-Naranjo, María Casanova-Espinosa, Antonio Rueda-Domínguez, Víctor Sánchez-Margalet, Luis de la Cruz-Merino
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundDiffuse large B cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma worldwide. DLBCL is an aggressive disease that can be cured with upfront standard chemoimmunotherapy schedules. However, in approximately 35-40% of the patients D
Externí odkaz:
https://doaj.org/article/212d6baeaf2d4c8bb7bf0ab05ba40793
Autor:
Carmen Fernandez-Alvarez, Arturo Rubio-Castro, Ana P Gonzalez-Rodriguez, Jackeline Solano, Ruben Fernández-Álvarez, Angel Ramirez Payer, Jesus E. Medina, Jose Manuel Alonso, M. Esther Gonzalez, Yahya Zanabili, Eva Alonso-Nogues, José Vicente, Juan M. Sancho, Francisco Dominguez-Iglesias
Publikováno v:
Leukemia & Lymphoma. 56:3096-3102
Ferritin levels might correlate with disease activity in classical Hodgkin lymphoma (cHL). We analyzed the prognostic significance of the ferritin value at diagnosis in 173 cHL patients treated with ABVD between 2003 and 2013. The 5-year overall surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366b69185194f0d43543d8e7babb46db
https://doi.org/10.3109/10428194.2015.1038709
https://doi.org/10.3109/10428194.2015.1038709
Publikováno v:
Annals of hematology. 97(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71548d53bda1eadd701216e02541d3b5
https://pubmed.ncbi.nlm.nih.gov/29234868
https://pubmed.ncbi.nlm.nih.gov/29234868
Autor:
Francisco-Javier Peñalver, Norma C. Gutiérrez, F. Gual, A. Batlle-López, Ruben Fernández-Álvarez, Esther González-García, Jorge Gayoso, Alejandro Martín, Jesús María Hernández-Rivas, J.M. Guinea, José-María Moraleda, M. Fuertes, Eva Gimeno, Eva González-Barca, C. Grande, Olga García, MJ Peñarrubia, Juan-Manuel Sancho
Publikováno v:
Hematological Oncology. 35:186-187
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f512c0a95862a4d573c353091a56723c
https://doi.org/10.1002/hon.2438_47
https://doi.org/10.1002/hon.2438_47
Autor:
Diana Rodriguez-Villar, Arturo Rubio-Castro, Ruben Fernández-Álvarez, Ana Alonso-Garcia, Angel Ramirez Payer, Ana P Gonzalez-Rodriguez, Juan M. Sancho, Francisco Dominguez-Iglesias, M. Esther Gonzalez
Publikováno v:
Leukemialymphoma. 57(2)
Plasmablastic lymphoma (PBL) is a rare sub-type of non-Hodgkin's lymphoma (NHL) strongly associated with human immunodeficiency virus (HIV) infection, accounting for 2% of all AIDS-related lymphoma...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9dc2364a32263602dd1ad7449fa1208
https://pubmed.ncbi.nlm.nih.gov/25976108
https://pubmed.ncbi.nlm.nih.gov/25976108
Autor:
Eva Domingo-Domenech, Ruben Fernández-Álvarez, Cristina Motlló, Helena Pomares, Miriam Moreno, Esther González-García, Juan-Manuel Sancho, Alberto Fernández-de-Sevilla, Evarist Feliu, Gustavo Tapia, Josep-Maria Ribera, Eva González-Barca, Olga García, José-Tomás Navarro, Marc Sorigue, Santiago Mercadal
Publikováno v:
Leukemia research. 39(8)
Local (involved-field or recently involved-site) radiotherapy is the standard therapy in limited-stage follicular lymphoma (FL). We retrospectively analyzed the value of chemotherapy in 130 patients with limited-stage FL (46 treated with radiotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8efd4c5bd2bbe20d64b25ca23ad085a
https://pubmed.ncbi.nlm.nih.gov/26122511
https://pubmed.ncbi.nlm.nih.gov/26122511
Publikováno v:
Medicina Clínica. 147:472-473
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a488e1ae5d0db15c37cc604cc389e2b0
https://doi.org/10.1016/j.medcli.2016.07.004
https://doi.org/10.1016/j.medcli.2016.07.004
Autor:
Juan-Manuel Sancho, Josep-Maria Ribera, Anna Sureda, Santiago Mercadal, Esther González-García, Evarist Feliu, Miriam Moreno, José-Tomás Navarro, Helena Pomares, Marc Sorigue, Ruben Fernández-Álvarez, Montserrat Garcia, Eva González-Barca, Olga García, Eva Domingo-Domenech, Cristina Motlló
Publikováno v:
Blood. 126:1510-1510
Background: Follicular lymphoma (FL) is the most frequent indolent lymphoma and is characterized by a high response to immunochemotherapy (ICT). However, patients refractory to first-line ICT have a worse prognosis. The objective of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b4f2a2ffdf79b6aa895b4c1d252cc03
https://doi.org/10.1182/blood.v126.23.1510.1510
https://doi.org/10.1182/blood.v126.23.1510.1510